MGB
OYST

Mass General Brigham’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Mass General Brigham’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,102
Closed -$1K – 8
2021
Q4 		$1K Buy
+2,102
New +$26.7K ﹤0.01% 7

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mass General Brigham's OYST Position: Q1 2022 in Review

Mass General Brigham sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 2,102 shares — an estimated $1K sold.

Mass General Brigham first reported a position in OYST in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

  • Mass General Brigham reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Mass General Brigham sold 2,102 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Mass General Brigham first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Mass General Brigham's Oyster Point Pharma, Inc. Common Stock position peaked at $1K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Mass General Brigham's 13F filing for Q1 2022, filed 15 Apr 2022.